Skip to main content
. 2015 Dec 11;7(3):3233–3244. doi: 10.18632/oncotarget.6564

Table 2. Correlation between SphK1 expression and clinicopathologic characteristics of ACC patients.

Ovearall
(n = 24)
Sphk1 Staining
Low
(n = 8)
High
(n = 16)
P
Age, y
≥ 50 13 4 9 1.000
< 50 11 4 7
Gender
Female 14 5 11 1.000
Man 10 3 5
Side
Right adrenal 13 3 10 0.390
Left adrenal 11 5 6
Tumor size
≥ 5.0 cm 17 2 15 0.001
< 5.0 cm 7 6 1
ENSAT Stage 0.023
1 5 4 1
2 7 3 4
3 10 1 9
4 2 0 2
Overall survival median (months) 17.5 34.5 14 0.03